The difference between participants with and without T2DM in the statistical significance of association between higher IL-6 levels, and diabetes-related biomarkers (plasma Glucose and HbA1c) levels raises new questions on the eventual beneficial effect of diabetes-related therapy (medication, diet, regular physical activity) on down-regulating diabetes-related systemic inflammation. This evidence concerns the gene IL6 and diabetes mellitus.